| Dr Lia R Matarrese Mcgibbon, DO | |
|
1910 Coalton Rd, Superior, CO 80027-4674 | |
| (720) 494-4700 | |
| (720) 494-4706 |
| Full Name | Dr Lia R Matarrese Mcgibbon |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 15 Years |
| Location | 1910 Coalton Rd, Superior, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144464454 | NPI | - | NPPES |
| 70976287 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 279671 (New York) | Secondary |
| 207RR0500X | Internal Medicine - Rheumatology | 50866 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Boulder Community Health | Boulder, CO | Hospital |
| Centura Health-avista Adventist Hospital | Louisville, CO | Hospital |
| Centura Health-st Anthony North Health Campus | Westminster, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New West Physicians Inc | 9537054614 | 150 |
News Archive
Cellectis S.A., the French genome engineering specialist, has announced that the European Patent Office has today upheld European Patent EP 1 485 475 owned by Cellectis and relating to the invention of engineering methods for meganucleases. This method is based on the genetic fusion of meganuclease modules to obtain hybrid meganucleases.
forMD, an innovative provider of specialty physician communities, has launched a private online community for alumni of Hospital for Special Surgery (HSS), one of the nation's leading orthopedic hospitals.
National Cancer Institute (NCI) scientists have discovered how human T-cell leukemia virus type 1 (HTLV-1), which infects about 20 million people worldwide, evades being held in check by one of the body's natural defense mechanisms.
Doubt has been cast on the popular practice of giving most heart patients drugs that reduce the heart's workload before and after major surgery, after new research has raised concerns about it.
› Verified 2 days ago
| Entity Name | New West Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427010859 PECOS PAC ID: 9537054614 Enrollment ID: O20040218000087 |
News Archive
Cellectis S.A., the French genome engineering specialist, has announced that the European Patent Office has today upheld European Patent EP 1 485 475 owned by Cellectis and relating to the invention of engineering methods for meganucleases. This method is based on the genetic fusion of meganuclease modules to obtain hybrid meganucleases.
forMD, an innovative provider of specialty physician communities, has launched a private online community for alumni of Hospital for Special Surgery (HSS), one of the nation's leading orthopedic hospitals.
National Cancer Institute (NCI) scientists have discovered how human T-cell leukemia virus type 1 (HTLV-1), which infects about 20 million people worldwide, evades being held in check by one of the body's natural defense mechanisms.
Doubt has been cast on the popular practice of giving most heart patients drugs that reduce the heart's workload before and after major surgery, after new research has raised concerns about it.
› Verified 2 days ago
| Entity Name | Colorado Center For Arthritis And Osteoporosis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013018001 PECOS PAC ID: 5799752168 Enrollment ID: O20040914001404 |
News Archive
Cellectis S.A., the French genome engineering specialist, has announced that the European Patent Office has today upheld European Patent EP 1 485 475 owned by Cellectis and relating to the invention of engineering methods for meganucleases. This method is based on the genetic fusion of meganuclease modules to obtain hybrid meganucleases.
forMD, an innovative provider of specialty physician communities, has launched a private online community for alumni of Hospital for Special Surgery (HSS), one of the nation's leading orthopedic hospitals.
National Cancer Institute (NCI) scientists have discovered how human T-cell leukemia virus type 1 (HTLV-1), which infects about 20 million people worldwide, evades being held in check by one of the body's natural defense mechanisms.
Doubt has been cast on the popular practice of giving most heart patients drugs that reduce the heart's workload before and after major surgery, after new research has raised concerns about it.
› Verified 2 days ago
| Entity Name | Optumcare Colorado Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407252828 PECOS PAC ID: 2769706431 Enrollment ID: O20150129000413 |
News Archive
Cellectis S.A., the French genome engineering specialist, has announced that the European Patent Office has today upheld European Patent EP 1 485 475 owned by Cellectis and relating to the invention of engineering methods for meganucleases. This method is based on the genetic fusion of meganuclease modules to obtain hybrid meganucleases.
forMD, an innovative provider of specialty physician communities, has launched a private online community for alumni of Hospital for Special Surgery (HSS), one of the nation's leading orthopedic hospitals.
National Cancer Institute (NCI) scientists have discovered how human T-cell leukemia virus type 1 (HTLV-1), which infects about 20 million people worldwide, evades being held in check by one of the body's natural defense mechanisms.
Doubt has been cast on the popular practice of giving most heart patients drugs that reduce the heart's workload before and after major surgery, after new research has raised concerns about it.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lia R Matarrese Mcgibbon, DO 1715 Iron Horse Dr Ste 100, Longmont, CO 80501-9617 Ph: (720) 494-4700 | Dr Lia R Matarrese Mcgibbon, DO 1910 Coalton Rd, Superior, CO 80027-4674 Ph: (720) 494-4700 |
News Archive
Cellectis S.A., the French genome engineering specialist, has announced that the European Patent Office has today upheld European Patent EP 1 485 475 owned by Cellectis and relating to the invention of engineering methods for meganucleases. This method is based on the genetic fusion of meganuclease modules to obtain hybrid meganucleases.
forMD, an innovative provider of specialty physician communities, has launched a private online community for alumni of Hospital for Special Surgery (HSS), one of the nation's leading orthopedic hospitals.
National Cancer Institute (NCI) scientists have discovered how human T-cell leukemia virus type 1 (HTLV-1), which infects about 20 million people worldwide, evades being held in check by one of the body's natural defense mechanisms.
Doubt has been cast on the popular practice of giving most heart patients drugs that reduce the heart's workload before and after major surgery, after new research has raised concerns about it.
› Verified 2 days ago
Dr. Lindsey M Rentschler, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3 Superior Dr Ste 100c, Superior, CO 80027 Phone: 303-415-4344 Fax: 303-425-9259 | |
Dr. Korina R Bersentes, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 936 Shavano Peak Dr, Superior, CO 80027 Phone: 303-912-8948 Fax: 303-494-5264 |